The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients

X Zhao, L Gan, FF Hou, X Liang, X Chen, Y Chen… - Renal …, 2024 - Taylor & Francis
Anemia is a common complication of chronic kidney disease with major option treatment of
erythropoiesis-stimulating agents (ESAs). This study aimed to investigate the influencing …

Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients

M Okazaki, M Komatsu, H Kawaguchi, K Tsuchiya… - Blood purification, 2014 - karger.com
Background: Evidence suggests hemodialysis (HD) patients with resistance to
erythropoiesis-stimulating agents (ESA) have a higher mortality rate. We investigated the …

High Erythropoiesis Resistance Index Is a Significant Predictor of Cardiovascular and All‐Cause Mortality in Chinese Maintenance Hemodialysis Patients

X Lu, J Zhang, S Wang, Q Yu, H Li - Mediators of inflammation, 2020 - Wiley Online Library
Background. Renal anemia is a common complication of hemodialysis patients.
Erythropoietin (EPO) hyporesponsiveness has been recognized as an important factor to …

Relationships among the dosage of erythropoiesis-stimulating agents, erythropoietin resistance index, and mortality in maintenance hemodialysis patients

S Pan, DL Zhao, P Li, XF Sun, JH Zhou, KK Song… - Blood …, 2022 - karger.com
Background: Erythropoiesis-stimulating agents (ESAs) constitute an important treatment
option for anemia in hemodialysis (HD) patients. We investigated the relationships among …

Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis

S Chung, HC Song, SJ Shin, SH Ihm… - Hemodialysis …, 2012 - Wiley Online Library
The response to erythropoietin (EPO) treatment varies considerably in individual patients on
chronic hemodialysis. The EPO resistance index (ERI) has been considered useful to …

[HTML][HTML] Factors contributing to erythropoietin hyporesponsiveness among hemodialysis patients: a cross-sectional multicenter study

S Samavat, M Nafar, A Khoshdel… - Nephro-urology …, 2017 - brieflands.com
Background: Anemia resistant to erythropoietin stimulating agents (ESAs) is a risk factor for
all-cause mortality. Determining the etiologies of hyporesponsiveness may help overcome …

Factors predicting erythropoietin resistance among maintenance hemodialysis patients

S Mallick, A Rafiroiu, R Kanthety, S Iqbal, R Malik… - Blood purification, 2012 - karger.com
Background: Erythropoiesis-stimulating agent (ESA) resistance remains incompletely
understood among hemodialysis (HD) patients. Method: A retrospective, multicenter study …

[PDF][PDF] Predictors of hyporesponsiveness to erythropoietin in prevalent hemodialysis patients and its association with mortality

M Roldão, R Duarte, R Escoli, H Gonçalves… - Port J Nephrol …, 2022 - researchgate.net
∎ ABSTRACT Introduction: Erythropoietin-stimulating agents hyporesponsiveness is
common among hemodialysis patients. The aim was to analyze factors predictive of …

Clinical significance of a novel reticulocyte‐based erythropoietin resistance index in HD patients: A retrospective study

E Ueda, T Fujikawa, Y Toya, T Kuji… - Therapeutic …, 2022 - Wiley Online Library
Introduction The erythropoietin resistance index (ERI) is an indicator of erythropoiesis‐
stimulating agent (ESA) responsiveness and is typically calculated using Hb. However, Hb …

[PDF][PDF] Impact of gender, C-reactive protein and body mass index on erythropoietin resistance index in maintenance hemodialysis patients

A Osman, NA Alkareem, B eldin Elawad… - Journal of Renal …, 2020 - jrenendo.com
Introduction: Anemia is caused by a variety of mechanisms in chronic kidney disease (CKD),
including erythropoietin (EPO) deficiency, resistance to erythropoiesis-stimulating agents …